Transforming Health Care: Insights From Industry Leaders on Health Equity and Policy
September 25th 2023At the National Comprehensive Cancer Network Oncology Policy Summit, prominent figures in the health care industry from diverse organizations emphasized a commitment to advancing health equity and addressing pressing social and health disparities.
What We’re Reading: RSV Vaccines for Pregnant Women; Medicaid Dental Care; Organ Transplant Bill
The CDC recommends pregnant women receive RSV vaccinations; 6 states expand their Medicaid programs to offer dental coverage; a new bill aims to address issues in the US organ transplant system
Updates Are Driving the Field of MDS Forward, but Changes Still Needed
September 25th 2023In just the last 2 years there have been updates in classification, risk assessment, and response criteria in myelodysplastic syndromes (MDS), but additional efforts are needed to improve these, and there remains a need for better therapies.
Patients With T1D Report Improved Management Using DIY-CGM vs isCGM
The study aimed to determine the perceived advantages and disadvantages of the smartwatch-integrated, do-it-yourself continuous glucose monitoring (DIY-CGM) device from the perspective of patients with type 1 diabetes (T1D).
Contributor: MA Plans Can Leverage Advanced Technology to Shore Up Risk Adjustment Practices
September 25th 2023Faced with new government regulations, Medicare Advantage (MA) organizations should be utilizing technology to increase the accuracy of their coding, mitigate their risk, and ensure appropriate care for members.
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Super-Refractory Status Epilepticus Linked With Unknown Etiologies, High Mortality Rates
Patients treated for more than 28 days had a higher chance of status epilepticus cessation, but also a high risk of moderate to severe disability at discharge, according to one study.
Autonomic Dysfunction Significantly Associated With Decreased Quality of Life in MS, NMOSD
September 23rd 2023Findings showed that autonomic symptom burden was slightly more severe in patients with multiple sclerosis (MS) compared with those with NMOSD, although the difference was not statistically significant.
Breast Cancer Risk Linked to Air Pollution Exposure
September 22nd 2023Data from 6 states—California, Florida, Louisiana, New Jersey, North Carolina, and Pennsylvania—and 2 metropolitan areas—Atlanta, Georgia, and Detroit, Michigan—collected through the National Institutes of Health–AARP Diet and Health Study were used for the investigation.
Sociodemographic, Clinical Variables Impact Metabolic Control in Adolescents With T1D
Self-care adherence, family support and functioning, and school support also indirectly affected the relationship between sociodemographic and clinical variables and metabolic control, a study found.
DNA Index Most Effectively Identifies Patients With Hyperdiploid ALL
The measure of total DNA in leukemic cells as defined by a DNA index outperformed other criteria for identifying patients with hyperdiploid acute lymphoblastic leukemia (ALL) and favorable prognosis.
Racial Differences in Chemokine Expression May Contribute to Prostate Cancer Disparities
Researchers found that analyzing certain chemokine levels may help explain racial disparities in prostate cancer lethality, and that neutralizing such chemokines could potentially benefit prostate cancer treatment.
BNP Levels May Not Be Effective Prognostic Tool for Patients With Cardiogenic Shock Using VADs
September 22nd 2023While B-type natriuretic peptide (BNP) levels remain high in patients with end-stage heart failure with cardiogenic shock, these levels lose their prognostic value in patients using ventricular assist devices (VADs).
Salvage RT Shows Local Control in LBCL After CAR T-Cell Therapy Failure
Salvage radiation therapy (RT) showed efficacy in local control of relapsed or refractory large B-cell lymphoma (LBCL) following CD19-targeted chimeric antigen receptor (CAR) T-cell therapy failure.